Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Uterine Cervical Neoplasms 2Ovarian Neoplasms 2Neoplasm Metastasis 2Multiple Myeloma 2Lymphoma 2Leukemia, Myeloid, Acute 2Hematologic Neoplasms 2Glioblastoma 2Carcinoma, Renal Cell 2Advanced Malignant Solid Neoplasm 2Vaginal Neoplasms 1Uterine Neoplasms 1Urinary Bladder Neoplasms 1Tongue Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumors 1Rhabdomyosarcoma 1Rectal Neoplasms 1Prostatic Neoplasms 1Pinealoma 1Pancreatic Neoplasms 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Neoplasms 1Myelodysplastic Syndromes 1Metastatic Pancreatic Adenocarcinoma 1Meningeal Carcinomatosis 1Melanoma 1

Interventions

entinostat 2Temozolomide 2Radiotherapy, Conformal 2Magnetic Resonance Spectroscopy 2Irinotecan 2Bevacizumab 2temsirolimus 1etoposide phosphate 1cixutumumab 1carboxyamido-triazole 1adavosertib 1Vorinostat 1Vincristine 1Verteporfin 1Thiotepa 1Surgical Procedures, Operative 1Radiotherapy, Intensity-Modulated 1Platinum 1Peripheral Blood Stem Cell Transplantation 1Paclitaxel 1Nivolumab 1Isotretinoin 1Immunoglobulin G 1Disulfides 1Cyclophosphamide 1Congresses as Topic 1Cisplatin 1Carboplatin 1Amplified Fragment Length Polymorphism Analysis 12-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Pinealoma × adavosertib × Clear all
NCT02095132 2023-09-26

Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors

National Cancer Institute (NCI)

Phase 1/2 Completed
76 enrolled 25 charts
CNSSarcoma

Medulloblastoma, Neuroblastoma, Pinealoma, Rhabdomyosarcoma, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡